Trial results for AstraZeneca’s experimental antibody, a potential replacement for Evusheld, could be out by September. The company is hoping for emergency use authorization by the end of 2023.
Incidence of tuberculosis up to 2.5 cases per 100,000 in US in 2022
Mar 23, 2023
Compared with 2021, in 2022, TB incidence was higher among persons aged 4 years and younger and 15 to 24 years and lower in those aged 65 years and older
Readmission rates, episode costs higher for patients with dementia
Mar 20, 2023
The cost of 30-day readmission and total 30-day episode costs are higher for patients with Alzheimer disease and related dementias, researchers report.
Symptom and viral RNA rebound common after mild, moderate COVID-19
Feb 21, 2023
For outpatients with mild-to-moderate COVID-19, symptom rebound and viral RNA rebound are relatively common, but the combination of symptom and viral rebound is rare, according to a study published online...
Risk for diabetes after COVID-19 still increased during omicron phase
Feb 14, 2023
The risk for diabetes is increased after COVID-19 infection, even during the current phase dominated by omicron variants, according to a research letter published online Feb. 14 in JAMA Network Open.
COVID-19 pneumonia more fatal for older adults
Feb 13, 2023
COVID-19 is associated with significantly higher mortality in older adults in the intensive care unit (ICU) versus pneumonias from bacterial or other viral etiologies, according to a study published online...
Ransomware attacks on healthcare organizations on the rise
Dec 29, 2022
Nearly twofold increase in annual number of attacks seen from 2016 to 2021, exposing information of nearly 42 million patients
BMI declines seen seven years before cognitive impairment diagnosis
Nov 02, 2022
Significantly lower body mass index (BMI) occurs beginning approximately seven years before a diagnosis of mild cognitive impairment (MCI), according to a study published online Oct. 26 in JAMA Psychiatry.
Untreated depression may increase later dementia risk
Oct 28, 2022
Symptomatic depression is associated with a 51% increased risk of dementia, according to a study published in Biological Psychiatry.
New model predicts five-year Alzheimer dementia risk
Oct 12, 2022
Model includes demographic information, brain imaging test results, and genetic biomarkers
